Basilea Pharmaceutica AG (BPMUF)
77.40
0.00 (0.00%)
USD |
OTCM |
Sep 25, 16:00
Basilea Pharmaceutica Research and Development Expense (TTM) : 153.18M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 153.18M |
| December 31, 2025 | 128.94M |
| June 30, 2025 | 94.36M |
| December 31, 2024 | 87.71M |
| June 30, 2024 | 101.45M |
| December 31, 2023 | 87.22M |
| June 30, 2023 | 61.51M |
| December 31, 2022 | 77.30M |
| June 30, 2022 | 95.27M |
| December 31, 2021 | 101.84M |
| June 30, 2021 | 104.54M |
| December 31, 2020 | 104.12M |
| June 30, 2020 | 97.95M |
| December 31, 2019 | 103.30M |
| June 30, 2019 | 98.43M |
| December 31, 2018 | 107.38M |
| June 30, 2018 | 87.55M |
| December 31, 2017 | 54.36M |
| Date | Value |
|---|---|
| June 30, 2017 | 50.56M |
| December 31, 2016 | 49.18M |
| June 30, 2016 | 54.78M |
| December 31, 2015 | 62.46M |
| June 30, 2015 | 61.57M |
| December 31, 2014 | 59.48M |
| June 30, 2014 | 59.86M |
| December 31, 2013 | 57.54M |
| June 30, 2013 | 57.33M |
| December 31, 2012 | 62.79M |
| June 30, 2012 | 83.83M |
| December 31, 2011 | 79.42M |
| June 30, 2011 | 52.18M |
| December 31, 2010 | 53.42M |
| June 30, 2010 | 62.15M |
| December 31, 2009 | 70.74M |
| June 30, 2009 | 82.80M |
| December 31, 2008 | 90.09M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Santhera Pharmaceuticals Holding AG | 26.72M |
| BeOne Medicines Ltd. | 2.220B |
| AC Immune SA | 57.87M |
| CRISPR Therapeutics AG | 263.69M |
| Idorsia Ltd. | 121.31M |